Carlos De Noronha

Title: Carlos De Noronha: Innovator in Viral Detection Technologies

Introduction

Carlos De Noronha is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of viral detection, particularly in relation to retroviral infections such as HIV. His innovative work has led to the development of a unique assay that enhances the detection of viral infections in target cells.

Latest Patents

Carlos holds a patent for a virion-based fusion assay. This invention features methods and compositions that allow for the detection of infection of a target cell by an enveloped retroviral virion, such as HIV. The assay utilizes virions containing a chimeric viral protein, which comprises a viral accessory polypeptide fused to a reporter polypeptide. The fusion of the virion with the target cell membrane enables the intracellular delivery of the chimeric protein, facilitating the detection of a signal mediated by the reporter polypeptide. This method ensures that significant detectable signals are only observed following productive viral entry, thereby excluding non-productive, endocytic entry of virions into the cell.

Career Highlights

Carlos De Noronha is affiliated with the J. David Gladstone Institutes, where he continues to advance his research in viral detection technologies. His work is crucial in understanding and combating viral infections, particularly in the context of public health.

Collaborations

Throughout his career, Carlos has collaborated with notable colleagues, including Warner C. Greene and Marielle Cavrois. These collaborations have further enriched his research and contributed to the advancement of innovative solutions in the field.

Conclusion

Carlos De Noronha's contributions to viral detection technologies exemplify the impact of innovative research in addressing critical health challenges. His work not only enhances our understanding of viral infections but also paves the way for improved diagnostic methods.